Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 60, Issue 1, 2005, Pages 61-66

  Cilurzo, Francesco ^a   Minghetti, Paola ^a   Casiraghi, Antonella ^a   Tosi, Leila ^a   Pagani, Stefania ^a   Montanari, Luisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Crystallization inhibitors; Eudragit ; Ibuprofen; Silicon PSA; Transdermal patches

Indexed keywords

BIO PSA; CREMOPHOR; DIMETICONE; EUDRAGIT; IBUPROFEN; POLYMETHACRYLIC ACID DERIVATIVE; PROPYLENE GLYCOL;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG RELEASE; DRUG STABILITY; EPIDERMIS; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; MOLECULAR WEIGHT; SENSITIVITY ANALYSIS; SKIN PERMEABILITY; STATISTICAL SIGNIFICANCE; STRATUM CORNEUM;

EID: 17444424224     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.02.001     Document Type: Article

References (17)

1. M.A. Pellet, J. Hadgraft, and A.F. Davis The permeation of solutions of piroxicam across silicon membranes and human skin in vitro Int. J. Pharm. 111 1994 1 6
2. M.A. Pellet, S. Castellano, J. Hadgraft, and A. Davis The permeation of solutions of piroxicam across silicon membranes and human skin in vitro J. Control. Rel. 46 1997 205 217
3. J.I. Kim, and H.K. Choi Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix Int. J. Pharm. 236 2002 81 85
4. J.J. Yu, T. Chien, and Y. Chien Transdermal dual-controlled delivery of testosterone and estradiol: (I) impact of system design Drug Dev. Ind. Pharm. 17 1991 1883 1904
5. P.S. Campbell, D.J. Enscore, R.M. Gale, A. Kaufman, Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a nonacqueous matrix, US Patent 4,832,953, 1989.
6. R. Lipp, J. Riedl, J. Tack, Transdermal therapeutic systems with crystallization inhibitors, US Patent 5,676,968, 1997.
7. R. Lipp, and A. Muller-Fahrnow Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems Eur. J. Pharm. Biopharm. 47 1999 133 138
8. F.I. Biali, A.F. Scasso, F.J.E. Stefano, Inhibition of crystallization in transdermal devices, US Patent 6,465,005, 2002.
9. X. Ma, J. Taw, and C.M. Chiang Control of drug crystallization in transdermal matrix system Int. J. Pharm. 142 1996 115 119
10. L. Rovati, A. Santoro, Transdermal patch for controlled release of estradiol and norethisterone acetate with reservoir based on polyacrylate adhesive and containing terpolymer crystallization inhibitor, WO 009966907, 1999.
11. P.N. Kotiyan, and P.R. Vavia Eudragits: role as crystallization inhibitors in drug in adhesive transdermal systems of estradiol Eur. J. Pharm. Biopharm. 52 2001 173 180
12. P. Minghetti, A. Casiraghi, F. Cilurzo, L. Montanari, M. Marazzi, L. Falcone, and V. Donati Comparison of different membranes with cultures of keratinocytes from man for percutaneous absorption of nitroglycerine J. Pharm. Pharmacol. 51 1999 673 678
13. PSTC-101 International Standard for Peel Adhesion of Pressure Sensitive Tape, revised 6/00 Test Methods for Pressure Sensitive Adhesive Tapes 13th ed. 2000 Pressure Sensitive Tape Council Stonebridge Lane, IL pp. 23-30
14. European Pharmacopeia 2.9.6 Uniformity of Content of Single-Dose Preparations, Stasbourg 4th ed. 2002 p. 200
15. S.G. Kazarian, and G.G. Martirosyan Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR-IR and Raman study of impregnation of ibuprofen into PVP Int. J. Pharm. 232 2002 81 90
16. T.P. Shakhtshneider, M.A. Vasiltchenko, A.A. Politov, and V.V. Boldyrev The mechanochemical preparation of solid disperse systems of ibuprofen-polyethylene glycol Int. J. Pharm. 130 1996 25 32
17. F.F. Fedors A method for estimating both the solubility parameters and molar volumes of liquids Polym. Eng. Sci. 14 1974 147 154